Mindray(SZ:300760) Zhao Yin Guo Ji·2025-06-16 02:40Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 272.90, reflecting a potential upside of 15.0% from the current price of RMB 237.28 [2][6]. Core Insights - The company is undergoing a digital and streamlined transformation, focusing on creating a comprehensive "equipment + IT + AI" and "equipment + consumables" solution across all departments [1]. - Key highlights include the establishment of a smart medical ecosystem based on IT and AI technologies, and the continuous expansion of business boundaries to support long-term growth [1][6]. - The report anticipates that the IT and AI business development cycle may take time to generate substantial revenue, but it will enhance product performance and competitiveness in the long run [6]. Financial Summary - Sales revenue is projected to grow from RMB 34,932 million in FY23A to RMB 49,573 million in FY27E, with a CAGR of approximately 10.9% [2][11]. - Net profit attributable to shareholders is expected to increase from RMB 11,582 million in FY23A to RMB 14,952 million in FY27E, reflecting a CAGR of about 10.3% [2][11]. - The company’s P/E ratio is forecasted to decrease from 24.8 in FY23A to 19.2 in FY27E, indicating improving valuation metrics [2][11]. Business Segments - The company is focusing on several key areas: - Life Information and Support Business: Utilizing AI to enhance clinical decision-making and patient care [6]. - Ultrasound Business: Offering AI-driven solutions to improve diagnostic efficiency and quality [6]. - In Vitro Diagnostics (IVD): Expanding automated production lines and launching new products to enhance market competitiveness [6]. - Emerging Business: Targeting interventional and minimally invasive treatments, with plans to develop surgical robots [6]. Valuation Analysis - The DCF valuation indicates a per-share value of RMB 272.90, based on a WACC of 9.2% and a perpetual growth rate of 3.0% [8]. - The report shows a slight upward adjustment in profit expectations, reflecting confidence in the company's growth trajectory [6][10].